Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients

The Journal of Clinical Investigation
S A SpectorM J Stempien

Abstract

In this study, baseline plasma from 619 persons with acquired immunodeficiency syndrome (AIDS) (median CD4+ lymphocyte count -21/microl) who participated in a trial to determine the efficacy of oral ganciclovir for cytomegalovirus (CMV) disease prevention were evaluated for CMV DNA load by qualitative and quantitative polymerase chain reaction (PCR), and correlated with the development of CMV disease and survival. For participants without detectable plasma CMV DNA, the 12-mo Kaplan-Meier CMV disease event rate was 14% and 1% for the placebo and ganciclovir groups, respectively (P < 0.001). For PCR positive participants, CMV disease developed in 43% of placebo and 26% ganciclovir recipients (P < 0.017). Among placebo recipients, CMV PCR positivity was associated with a 3.4-fold increased risk of developing CMV disease (P < 0.001) whereas CD4+ lymphocyte count was not a useful predictor (P = 0.47). A positive plasma CMV DNA PCR was also associated with a 2.5-fold increased risk of death. Each log10 increase in baseline CMV DNA load was associated with a 3.1-fold increase in CMV disease (P < 0.001) and a 2.2-fold increase in mortality (P < 0.001). These data indicate that the risk of developing CMV disease and death in persons wit...Continue Reading

References

Feb 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·W L Drew
Sep 1, 1990·Reviews of Infectious Diseases·L D FrenkelH Kesarwala
Dec 15, 1988·Annals of Internal Medicine·J N Bloom, A G Palestine
Apr 1, 1994·The Journal of Infectious Diseases·R DetelsJ V Giorgi
Sep 5, 1996·The New England Journal of Medicine·C S Crumpacker

❮ Previous
Next ❯

Citations

Oct 27, 1999·Journal of Medical Virology·S B MostadL Corey
Oct 25, 2001·Antiviral Research·B W van der StrateD K Meijer
May 14, 2003·Antiviral Research·Barry W A van der StrateMartin C Harmsen
Dec 2, 1998·Antiviral Research·M D de JongS A Spector
Apr 17, 2002·Virus Research·Maja StanojevicJovan Ranin
Jan 6, 2001·Infectious Disease Clinics of North America·W Tantisiriwat, W G Powderly
Nov 24, 1999·International Journal of Antimicrobial Agents·M Jouan, C Katlama
Jul 20, 2002·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·B S N BlankJ M A Lange
Dec 18, 2001·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Astrid E GreijerJaap M Middeldorp
Jul 20, 2002·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·D PillayUNKNOWN Public Health Laboratory Service Advisory Committee on Virology
Feb 19, 2003·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Wolfgang PreiserJeremy A Garson
Sep 6, 2003·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Alexandra MichaelidesThomas Kotsimbos
Feb 19, 2000·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·W G Nichols, M Boeckh
Jun 29, 2001·Transplant Infectious Disease : an Official Journal of the Transplantation Society·P D GriffithsV C Emery
May 3, 2000·Clinical and Experimental Immunology·I NordøyS S Frøland
Aug 4, 1999·The Journal of Experimental Medicine·V C EmeryP D Griffiths
Oct 6, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·G A Storch
Mar 7, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A D PaltielK A Freedberg
Oct 20, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A YoshidaS Kimura
Aug 9, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A EriceUNKNOWN AIDS Clinical Trials Group Protocol 360 Study Team
Oct 30, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John H KempenJames Tonascia
Mar 21, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Nicolas DurierAnchalee Avihingsanon
Apr 24, 2004·The American Journal of Surgical Pathology·Neeraja KambhamTeri Longacre
Oct 7, 2006·Current Opinion in Gastroenterology·G Meng, P D Smith
May 31, 2001·Critical Care Medicine·P E Marik, A Weinmann
Jul 11, 2006·Proceedings. Biological Sciences·Roland R RegoesVincent C Emery
Apr 3, 2001·Journal of Clinical Microbiology·A M CaliendoUNKNOWN CMV Working Group of the Complications of HIV Disease RAC, AIDS Clinical Trials Group
Jun 29, 2002·Journal of Clinical Microbiology·Jason L Sanchez, Gregory A Storch
Aug 9, 2003·Journal of Clinical Microbiology·Angela M CaliendoNell S Lurain

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.